Human genetics of steatotic liver disease: insights into insulin resistance and lipid metabolism.

Abstract excerpt

Metabolic-dysfunction-associated steatotic liver disease (MASLD, previously known as non-alcoholic fatty liver disease or NAFLD) is a prevalent and heterogeneous condition affecting nearly 30% of the global population. MASLD is defined as excessive hepatic lipid accumulation with at least one feature of insulin resistance, with potential progression to metabolic dysfunction-associated steatohepatitis, cirrhosis...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Fatty Liver
• Share to Genetic Risk Score
• Share to Genetic Variation